Bone Mets

- A Network of Your Peers More Bone Mets Videos >>

Dr. George on Radium-223 in Advanced Prostate Cancer

Dr. Morris Discusses PET Imaging in Prostate Cancer

Dr. Gomella on Radium-223 in Advanced Prostate Cancer

Dr. Sandler on the Unique Characteristics of Radium-223

Latest Bone Mets Articles View more >>

Radium-223 Approved For Advanced Prostate Cancer

The FDA approved radium RA 223 dichloride for the treatment of symptomatic metastatic castration-resistant prostate cancer that has spread to the bones but not to any other organs.

> Web Exclusives

Bone-Targeted Therapies Evolve in Prostate Cancer

The treatment of bone metastases in prostate cancer has changed over the years, and several options are now either available or under development.

> Web Exclusives

Trials in Progress: Bone Metastases

The Trials in Progress series is intended to stimulate discussion about ongoing clinical trials, to promote collaboration across the oncology community.

> Web Exclusives

Microwave Ablation Is Potentially Effective in Treating Bone and Soft-Tissue Tumor Pain

A small study found that microwave ablation therapy reduced pain associated with bone and soft tissues by half in the majority of patients treated with the technique.

> Web Exclusives

FDA Gives Radium-223 Priority Review Status

Radium Ra 223 Dichloride will be considered as a treatment for patients who have castration-resistant prostate cancer with bone metastases under the FDA’s priority review program.

> Web Exclusives